Form 8.3 SPIRE HEALTHCARE GROUP PLC

Summary by AI BETAClose X

Barclays disclosed on 06 Nov 2026 that as at 05 Nov 2026 it held 6,915,506 Spire Healthcare 1p ordinary shares (1.72%) and short positions of 6,531,933 shares (1.62%); cash-settled derivatives comprised 6,527,957 long (1.62%) and 6,948,484 short (1.73%), giving total economic interests of 13,443,463 shares (3.34%) and total short exposure of 13,480,417 shares (3.35%). Barclays executed multiple purchases, sales and swaps at around £2.48 per share on 05 Nov 2026, including a notable sale of 604,586 shares at £2.485. No stock-settled derivatives, indemnities or related arrangements were reported.

Disclaimer*

UK 100

Latest directors dealings